| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-12-20 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | $410.00 | – | $847.00 | $0.00 |
| Cost of Revenue | – | – | $3.55K | – | $5.05K | – |
| Gross Profit | – | – | -$3.14K | – | -$4.21K | – |
| Operating Expenses | $1.02M | $1.89M | $3.96M | – | $5.67M | $10.30M |
| R&D | – | – | – | – | – | – |
| SG&A | $1.02M | $1.88M | $3.58M | – | $5.54M | $10.28M |
| Operating Income | -$1.02M | -$1.89M | -$3.96M | – | -$5.68M | -$10.30M |
| Interest Expense | $238.10K | $119.15K | $319.54K | $2.51K | $193.89K | $221.93K |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$4.39M | -$4.55M | -$5.84M | – | -$10.29M | -$14.49M |
| EPS (basic) | -0.0200 | -0.3000 | -0.4500 | – | -0.0300 | -0.0400 |
| EPS (diluted) | -0.0200 | -0.3000 | -0.4500 | – | -0.0300 | -0.0400 |
| Shares (diluted) | $317.10M | $15.08M | $12.84M | – | $372.20M | $334.34M |